Biocon Trades Higher After USFDA Completes Inspection at Bengaluru Facility
Mumbai, September 5 (Kiran News) — Shares of Biocon were trading higher on Friday after the company announced that the US Food and Drug Administration (USFDA) had completed a routine cGMP inspection at the drug substance facility of its subsidiary Biocon Biologics (BBL) in Bengaluru. At 11:00 am, the stock was quoted at ₹361.60, up … Read more
